Drug Safety Center Update: Employee Alleges Actos Maker Valued Sales Over Safety - KOAM TV 7

Drug Safety Center Update: Employee Alleges Actos Maker Valued Sales Over Safety

This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

SOURCE: DrugRisks

http://www.DrugRisks.com is the most helpful resource on the web for prescription medication alerts, side effects and legal news. Visit us today!

Philadelphia, PA (PRWEB) March 21, 2013

The medication safety advocates at DrugRisks.com are announcing updated information on the site for patients who have taken the diabetes drug Actos. In an ongoing trial over Actos bladder cancer side effects*, a former employee recently alleged in testimony that drug maker Takeda put profit concerns over safety.

DrugRisks was created to provide those taking popular prescription drugs with the latest safety alerts, recalls, studies and legal news. Visitors can determine if other patients are experiencing similar side effects and decide if they need legal advice for current litigation.

Health experts with the FDA** and European Medicines Agency*** have warned patients that long-term use of Actos may be linked to increased risks of bladder cancer. The drug has also been banned in France and Germany****.

The maker of Actos, Takeda Pharmaceuticals, now faces Actos lawsuits from as many as 3,000 patients over bladder cancer*****. Over 1,200 of these have been consolidated in a special multi-district federal court in Louisiana, while others are pending in California.

DrugRisks has added information showing the first Actos lawsuit trial in California* began this month for a man dying of bladder cancer*****. Also, a former pharmacologist for Takeda testified that company emails suggested they were more concerned with continued sales of the drug rather than the safety of patients*****.

Although trials have begun, lawyers are still helping those diagnosed with bladder cancer after taking Actos file claims. Anyone affected is urged to contact the DrugRisks Safety Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of drug injury litigation against large pharmaceutical companies, DrugRisks only recommends lawyers and law firms who have already handled Actos lawsuits.
Visit http://www.DrugRisks.com today for more information on Actos bladder cancer research, side effects and litigation news, or to speak with a lawyer.

*Cooper v. Takeda Pharmaceuticals America, Inc., CGC-12-518535, California Superior Court (Los Angeles)
**http://www.fda.gov/Drugs/DrugSafety/ucm259150.htm
***http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/public_health_alerts/2011/07/human_pha_detail_000033.jsp&mid=WC0b01ac058001d126&source=homeMedSearch&category=human
****cbsnews.com/8301-504763_162-20070492-10391704.html
*****bloomberg.com/news/2013-03-05/takeda-put-actos-sales-ahead-of-user-safety-witness-says.html

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebactos-lawsuit/actos-lawsuits/prweb10547940.htm

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.